top of page

News

Disturbing Picture Of Lilly, Zyprexa Promotion May Cost Them Over $1 Billion In Fines

February 1, 2008

Share to:

Eli Lilly and federal prosecutors are discussing a possible settlement of both civil and criminal investigations that will amount to more than $1 billion in payments to federal and state governments. Lilly has been accused of breaking federal laws by "off-label marketing" its psychotherapeutic drug, Zyprexa, for uses not approved by the Food and Drug Admistration.
<a href="http://www.nytimes.com/2008/01/31/business/31drug.html?scp=3&amp;sq=lilly&amp;st=nyt">http://www.nytimes.com/2008/01/31/business/31drug.html?scp=3&amp;sq=lilly&amp;st=nyt</a>

Headshot of Staff Member
Button
Button
Button
Button

Contact

bottom of page